| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 701022 | Null | 0.0237269271456697 | 0.25756781 |
| NSC 709358 | 1H-Pyrrole-2-carboxamide, N-[3-(dimethylamino)propyl]-1-methyl-4-[[[1-methyl- 4-[[1-oxo-4-[[(2,3,5,11a-tetrahydro-7-methoxy-5-oxo- 1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl]oxy]butyl]amino]- 1H-pyrrol | 0.0237269271456697 | 0.17408345 |
| NSC 710326 | Null | 0.0237269271456697 | -0.1111109 |
| NSC 715407 | Null | 0.0237269271456697 | 0.058717162 |
| NSC 717468 | Null | 0.0237269271456697 | 0.22716926 |
| NSC 719667 | 7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one | 0.0237269271456697 | 0.10375719 |
| NSC 720134 | Null | 0.0237269271456697 | -0.20928544 |
| NSC 726089 | 11-(4-dimethylaminobenzyliden)-8-methoxy-5-methyl-11H-indolo [1,2-b]indazolium trifluoromethanesulfonate | 0.0237269271456697 | 0.14453229 |
| NSC 731701 | 1[(4-n-butyloxyCarbonyl)piperazine-1-yl]diazene-1-ium-1,2-di olate | 0.0237269271456697 | -0.14881279 |
| NSC 734949 | 4-[3-(3,4-dihydro-1H-isoquinolin-2-yl)prop-1-en-2-yl]-N-pyrazin-2-ylbenzamide | 0.0237269271456697 | 0.184271 |